SYNAIRGEN RESEARCH LIMITED
Company number 04793696 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2003-06-10
- Registered office
- 4th Floor 95 Gresham Street, London, EC2V 7AB
- Postcode
- EC2V 7AB
- Capital
- 1,400 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-05-26
- Next due by
- 2027-06-09
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 10 resigned
Mark, Dr PARRY-BILLINGS
Director
Joseph Tregonning COLLIVER
Secretary
Joseph Tregonning COLLIVER
Director
Group structure
Controlled by SYNAIRGEN LIMITED — since 2016-04-06
From persons-with-significant-control filings on the public register.
Contact details
- Website
- synairgen.com
A drug discovery company specialising in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease (COPD)
Previous company names
| Name | Date changed |
|---|---|
| SYNAIRGEN LIMITED | 2004-10-12 |
The class of 2003
38%
of the 163,089 companies incorporated in 2003 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.